Phase I study of Navitoclax (ABT-263), a novel Bcl-2 family inhibitor, in patients with small-cell lung cancer and other solid tumors
published in: Journal of Clinical Oncology
date of publication: 2011-01-31
language: English
main subject: lung cancer
Cites articles 34
Date
Title
Article - wd:Q33393931